NetDr.com Since 1998 source for: Viagra [ sildenafil citrate ], Propecia/Proscar [ finasteride ], Cialis and Levitra.

Cart | Login

Medications

Hair Loss

Weight Loss

Xenical

Cosmetic

Latisse

Sexual Health

Skin Care

Columbia study suggests benefits of Zyflamend® in the early treatment of prostate cancer 2005-11-09

By Craig LeMoult

Data from the Columbia University Department of Urology demonstrates that Zyflamend®, a unique herbal extract preparation, suppresses the growth of prostate cancer cells and induces prostate cancer cells to self-destruct via a process called "

All done in four hours - and no threat to men's virility 2005-11-06

By David Derbyshire

Shortly before 10.30am last Saturday,, Jonathan Cawley lay down on an operating table in central London to begin treatment with HIFU.

Merck Prevails in Second Vioxx Case on Heart Attack 2005-11-04

By Alex Berenson

Merck Prevails in Second Vioxx Case on Heart Attack

Vitamin D, taxotere combination extends the lives of men with advanced prostate cancer 2005-11-02

By Rachel MacKnight

Men with advanced prostate cancer who take an experimental, high-dose vitamin D pill with chemotherapy live about eight months longer than those receiving chemotherapy and placebo, according to a new study.

Jury Begins to Deliberate Vioxx Case 2005-11-02

By Alex Berenson

Jury Begins to Deliberate Vioxx Case

Protein suppresses prostate cancer, enhances effects of vitamin E 2005-11-01

By Michael Wentzel

Researchers have identified a protein that disrupts an important signaling pathway in prostate cancer cells and suppresses growth of the cancer.

Long-term hormone use helps prostate cancer patients live longer 2005-11-01

By Bet Bukata

Doctors in Canada have discovered that treating high-risk prostate cancer patients with radiation therapy and adding hormone therapy for more than one year allows patients to live longer, have better control of their prostate specific antigen levels an

Vitamin D compounds show promise for prevention of prostate cancer 2005-11-01

By Warren Froelich

The active metabolite of vitamin D, calcitriol, and other vitamin D analogs are promising chemopreventive agents that may prevent prostate cancer, according to a study presented today at the American Association for Cancer Research's 4th annual Frontie

Merck Lawyer Impugns Story in Vioxx Suit 2005-11-01

By Alex Berenson

Merck Lawyer Impugns Story in Vioxx Suit

Injustices at Work May Harm Men's Hearts 2005-11-01

By Eric Nagourney

Injustices at Work May Harm Men's Hearts

Viagra may help reduce stress in more ways than previously imagined 2005-10-25

By Celia Hall

Viagra, used to treat impotence in men, has been found to reduce the harmful effects of stress on the heart, scientists said yesterday.

Research On Bicycle Saddles And Sexual Health Comes Of Age 2005-10-24

By Science Daily

Steven Schrader, a prominent researcher in sexual and reproductive health, philosophized in a guest editorial of the September issue of The Journal of Sexual Medicine that it is time to move on - the current scientific focus on the relationship between

Viagra blunts effects of stress on the human heart 2005-10-24

By David March

Sildenafil citrate (Viagra), a drug used to treat erectile dysfunction (ED) in millions of men, reduces the stimulatory effects of hormonal stress on the heart by half, according to results of a new study by researchers at Johns Hopkins.

Annual prostate cancer screening test appears to save lives 2005-10-19

By Beth Bukata

Men who have a yearly blood test to examine their prostate specific antigen levels are nearly three times less likely to die from prostate cancer than those who don't have annual screenings, according to a study presented October 19, 2005, at the Ameri

Decision Is Delayed on Diabetes Drug That Lowers Cholesterol 2005-10-19

By Stephanie Saul

Decision Is Delayed on Diabetes Drug That Lowers Cholesterol

UCLA researchers identify how antibody blocks prostate cancer growth in animal models 2005-10-17

By Kim Irwin

Researchers at UCLA's Jonsson Cancer Center have uncovered the mechanism by which an antibody blocks the growth of prostate cancer in animal models, a discovery that could pave the way for development of a new molecularly targeted therapy.

Have researchers found a biomarker to signal a more agressive form of prostate cancer? 2005-10-17

By Karen C. Mallet

Researchers say they have identified a biomarker that indicates a more agressive form of prostate cancer. Fox Chase Cancer Center's chairman of radiation oncology, Alan Pollack, M.D., Ph.D., presented the findings today at the 47th Annual Meeting of th

No effects of type II diabetes on aggressiveness of prostate cancer; long-term survival worse 2005-10-16

By Karen C. Mallet

Researchers at Fox Chase Cancer Center found no effects of type II diabetes on aggressiveness of prostate cancer but found that long-term survival is worse. The findings were presented today at the 47th Annual Meeting of the American Society for Therap

Fox Chase study shows TURP patients with intermediate PSA should be considered high-risk 2005-10-16

By Karen C. Mallet

Researchers at Fox Chase Cancer Center recommend more aggressive treatment for men whose prostate cancers occurred after transurethral resection of the prostate (TURP) and whose PSA level is considered intermediate.

Erectile Dysfunction May Signal Early Atherosclerosis 2005-10-12

By Science Daily

Erectile dysfunction may be a sign that coronary artery disease is developing, even in men without typical risk factors, according to a new study in the Oct. 18, 2005, issue of the Journal of the American College of Cardiology.

READ MORE

<<... <... 631 632 633 634 635 636 637 638 639 640 ...> ...>>

Patent Pending: 60/481641

Email Us

About Us Privacy Policy Doctor Login